{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:20:57Z","timestamp":1792081257548,"version":"4.4.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20295"],"award-info":[{"award-number":["U22A20295"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82188101"],"award-info":[{"award-number":["82188101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["2025"],"award-info":[{"award-number":["2025"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["22JC1410400"],"award-info":[{"award-number":["22JC1410400"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cell.2025.11.035","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:12:30Z","timestamp":1767888750000},"page":"6-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Next steps in regulatory T cells: Biology and clinical application"],"prefix":"10.1016","volume":"189","author":[{"given":"Chengyu","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Sparwasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2405-6036","authenticated-orcid":false,"given":"Junying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2025.11.035_bib1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cell.2025.11.035_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cell.2025.11.035_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib6","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.cell.2025.11.035_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1084\/jem.20061852","article-title":"Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease","volume":"204","author":"Lahl","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2025.11.035_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ni1428","article-title":"Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice","volume":"8","author":"Kim","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/83707","article-title":"X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy","volume":"27","author":"Wildin","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cell.2025.11.035_bib10","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood.2024026446","article-title":"Donor regulatory T-cell therapy to prevent graft-versus-host disease","volume":"145","author":"Meyer","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.cell.2025.11.035_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adn2404","article-title":"A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes","volume":"16","author":"Bender","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2025.11.035_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147474","article-title":"The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes","volume":"6","author":"Dong","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.cell.2025.11.035_bib13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nm.1927","article-title":"Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke","volume":"15","author":"Liesz","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2025.11.035_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-023-00692-7","article-title":"Amyloid-beta specific regulatory T cells attenuate Alzheimer's disease pathobiology in APP\/PS1 mice","volume":"18","author":"Yeapuri","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cell.2025.11.035_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-025-03609-8","article-title":"LdIL-2 treatment in ASD: a novel immunotherapeutic approach targeting Th\/Treg dysfunction and neuroinflammation","volume":"15","author":"Li","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.cell.2025.11.035_bib16","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0140-6736(25)00262-4","article-title":"Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial","volume":"405","author":"Bensimon","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2025.11.035_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-025-01791-x","article-title":"Low-dose interleukin-2 in patients with mild to moderate Alzheimer's disease: a randomized clinical trial","volume":"17","author":"Faridar","year":"2025","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.cell.2025.11.035_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/eji.200636435","article-title":"Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells","volume":"37","author":"Wang","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2025.11.035_bib20","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1182\/blood-2009-05-219584","article-title":"Epigenetic mechanisms of regulation of Foxp3 expression","volume":"114","author":"Lal","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cell.2025.11.035_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/86302","article-title":"Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide","volume":"2","author":"Jordan","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.11.035_bib23","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.4049\/jimmunol.178.4.2018","article-title":"IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells","volume":"178","author":"Zheng","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib24","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41586-020-2246-4","article-title":"CRISPR screen in regulatory T cells reveals modulators of Foxp3","volume":"582","author":"Cortez","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.11.035_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adr7057","article-title":"Inducible protein degradation reveals inflammation-dependent function of the Treg cell lineage-defining transcription factor Foxp3","volume":"10","author":"J\u00e4ger","year":"2025","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib26","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1038\/s41590-025-02295-4","article-title":"Temporal and context-dependent requirements for the transcription factor Foxp3 expression in regulatory T cells","volume":"26","author":"Hu","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nature05673","article-title":"Foxp3 controls regulatory T-cell function by interacting with AML1\/Runx1","volume":"446","author":"Ono","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.11.035_bib28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.coi.2006.05.007","article-title":"Imaging the function of regulatory T cells in vivo","volume":"18","author":"Tang","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib29","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41590-018-0280-2","article-title":"Regulatory T cells mediate specific suppression by depleting peptide-MHC class II from dendritic cells","volume":"20","author":"Akkaya","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.cell.2025.11.035_bib31","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.immuni.2025.03.004","article-title":"Soluble CTLA-4 regulates immune homeostasis and promotes resolution of inflammation by suppressing type 1 but allowing type 2 immunity","volume":"58","author":"Osaki","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2025.11.035_bib32","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jaci.2016.08.034","article-title":"Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction","volume":"139","author":"Rigas","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.iy.11.040193.001333","article-title":"The IL-2 receptor complex: its structure, function, and target genes","volume":"11","author":"Minami","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","article-title":"Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces","volume":"28","author":"Rubtsov","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2025.11.035_bib35","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.immuni.2015.04.012","article-title":"Integrin \u03b1v\u03b28-Mediated TGF-\u03b2 Activation by Effector Regulatory T Cells Is Essential for Suppression of T-Cell-Mediated Inflammation","volume":"42","author":"Worthington","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2025.11.035_bib36","doi-asserted-by":"crossref","first-page":"13445","DOI":"10.1073\/pnas.0901944106","article-title":"GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells","volume":"106","author":"Tran","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2025.11.035_bib37","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1002\/eji.200939684","article-title":"Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg","volume":"39","author":"Stockis","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib38","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni.1952","article-title":"IL-35-mediated induction of a potent regulatory T cell population","volume":"11","author":"Collison","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib39","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.immuni.2004.09.002","article-title":"Human T regulatory cells can use the perforin pathway to cause autologous target cell death","volume":"21","author":"Grossman","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2025.11.035_bib40","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1182\/blood-2006-01-0177","article-title":"Regulatory T-cell compartmentalization and trafficking","volume":"108","author":"Wei","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cell.2025.11.035_bib41","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1084\/jem.20170277","article-title":"CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes","volume":"216","author":"Rapp","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2025.11.035_bib42","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.immuni.2023.01.033","article-title":"The gut microbiota promotes distal tissue regeneration via ROR\u03b3+ regulatory T cell emissaries","volume":"56","author":"Hanna","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2025.11.035_bib43","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nm.2002","article-title":"Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters","volume":"15","author":"Feuerer","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2025.11.035_bib44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1126\/science.adq6531","article-title":"Meningeal regulatory T cells inhibit nociception in female mice","volume":"388","author":"Midavaine","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.cell.2025.11.035_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adu2910","article-title":"The meninges host a distinct compartment of regulatory T cells that preserves brain homeostasis","volume":"10","author":"Marin-Rodero","year":"2025","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","article-title":"The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function","volume":"20","author":"Macintyre","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.cell.2025.11.035_bib47","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/ni.3577","article-title":"Foxp3 and toll-like receptor signaling balance Treg cell anabolic metabolism for suppression","volume":"17","author":"Gerriets","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib48","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.immuni.2016.01.028","article-title":"The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements","volume":"44","author":"Procaccini","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2025.11.035_bib49","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.cell.2025.11.035_bib50","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1053\/j.gastro.2021.04.041","article-title":"MondoA-Thioredoxin-Interacting Protein Axis Maintains Regulatory T-Cell Identity and Function in Colorectal Cancer Microenvironment","volume":"161","author":"Lu","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cell.2025.11.035_bib51","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/s42255-025-01347-1","article-title":"Targeting MondoA-TXNIP restores antitumour immunity in lactic-acid-induced immunosuppressive microenvironment","volume":"7","author":"Xu","year":"2025","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cell.2025.11.035_bib52","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib53","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cmet.2018.06.002","article-title":"Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation","volume":"28","author":"Raud","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.cell.2025.11.035_bib54","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/nm.3704","article-title":"De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells","volume":"20","author":"Berod","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2025.11.035_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2025.102111","article-title":"ACC1 is a dual metabolic-epigenetic regulator of Treg stability and immune tolerance","volume":"94","author":"St\u00fcve","year":"2025","journal-title":"Mol. Metab."},{"key":"10.1016\/j.cell.2025.11.035_bib56","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","article-title":"The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment","volume":"30","author":"Delgoffe","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2025.11.035_bib57","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nature12297","article-title":"mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function","volume":"499","author":"Zeng","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.11.035_bib58","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","article-title":"Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients","volume":"177","author":"Battaglia","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib59","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2017.10.017","article-title":"Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis","volume":"47","author":"Kishore","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2025.11.035_bib60","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cmet.2019.09.010","article-title":"Roles of Regulatory T Cells in Tissue Pathophysiology and Metabolism","volume":"31","author":"Campbell","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.cell.2025.11.035_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04908-z","article-title":"Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction","volume":"9","author":"Zacchigna","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2025.11.035_bib62","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.7150\/thno.32734","article-title":"Regulatory T-cells regulate neonatal heart regeneration by potentiating cardiomyocyte proliferation in a paracrine manner","volume":"9","author":"Li","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.cell.2025.11.035_bib63","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2013.10.054","article-title":"A special population of regulatory T cells potentiates muscle repair","volume":"155","author":"Burzyn","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.cell.2025.11.035_bib64","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-018-0824-5","article-title":"Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery","volume":"565","author":"Ito","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.11.035_bib65","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nn.4528","article-title":"Regulatory T cells promote myelin regeneration in the central nervous system","volume":"20","author":"Dombrowski","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cell.2025.11.035_bib66","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-024-03262-w","article-title":"MOG-specific CAR Tregs: a novel approach to treat multiple sclerosis","volume":"21","author":"Frikeche","year":"2024","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.cell.2025.11.035_bib67","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/ni.3540","article-title":"An essential role for the IL-2 receptor in Treg cell function","volume":"17","author":"Chinen","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib68","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.4049\/jimmunol.1202659","article-title":"TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment","volume":"190","author":"Chen","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib69","doi-asserted-by":"crossref","first-page":"13051","DOI":"10.1073\/pnas.1807499115","article-title":"Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity","volume":"115","author":"Atretkhany","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2025.11.035_bib70","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.41451","article-title":"Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjogren Syndrome: A Randomized Clinical Trial","volume":"5","author":"He","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.cell.2025.11.035_bib71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.celrep.2016.12.022","article-title":"c-FLIP Expression in Foxp3-Expressing Cells Is Essential for Survival of Regulatory T Cells and Prevention of Autoimmunity","volume":"18","author":"Plaza-Sirvent","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2025.11.035_bib72","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/ni.3868","article-title":"Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor","volume":"18","author":"Maj","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib73","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","article-title":"A guide to cell death pathways","volume":"25","author":"Yuan","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cell.2025.11.035_bib74","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41423-023-01113-x","article-title":"RIPK1 plays a crucial role in maintaining regulatory T-Cell homeostasis by inhibiting both RIPK3- and FADD-mediated cell death","volume":"21","author":"Deng","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib75","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jaci.2006.10.007","article-title":"CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes","volume":"119","author":"Caudy","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib76","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.cell.2025.11.035_bib77","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cell.2025.11.035_bib78","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41586-020-2040-3","article-title":"Sex-specific adipose tissue imprinting of regulatory T cells","volume":"579","author":"Vasanthakumar","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.11.035_bib79","doi-asserted-by":"crossref","first-page":"e710","DOI":"10.1016\/S2665-9913(22)00198-9","article-title":"Investigating sex differences in T regulatory cells from cisgender and transgender healthy individuals and patients with autoimmune inflammatory disease: a cross-sectional study","volume":"4","author":"Robinson","year":"2022","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.cell.2025.11.035_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00493","article-title":"FOXP3(+) Treg Cells and Gender Bias in Autoimmune Diseases","volume":"6","author":"Nie","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib81","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1172\/JCI0213605","article-title":"Multiple immuno-regulatory defects in type-1 diabetes","volume":"109","author":"Kukreja","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cell.2025.11.035_bib82","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2337\/db06-1248","article-title":"No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes","volume":"56","author":"Brusko","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.cell.2025.11.035_bib83","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2337\/diabetes.54.1.92","article-title":"Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes","volume":"54","author":"Lindley","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.cell.2025.11.035_bib84","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/eji.201344280","article-title":"Regulatory T cells in systemic lupus erythematosus","volume":"45","author":"Ohl","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib85","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa073493","article-title":"Risk alleles for multiple sclerosis identified by a genomewide study","volume":"357","author":"Hafler","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2025.11.035_bib86","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.molmed.2009.12.003","article-title":"Disturbed regulatory T cell homeostasis in multiple sclerosis","volume":"16","author":"Venken","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.cell.2025.11.035_bib87","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89530","article-title":"ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity","volume":"2","author":"Beers","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.cell.2025.11.035_bib88","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JAD-2009-1015","article-title":"Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease","volume":"17","author":"Larbi","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.cell.2025.11.035_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-021-00188-5","article-title":"Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson's disease","volume":"7","author":"Thome","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.cell.2025.11.035_bib90","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-023-06300-4","article-title":"Co-transplantation of autologous Treg cells in a cell therapy for Parkinson's disease","volume":"619","author":"Park","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.11.035_bib91","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-024-03388-5","article-title":"Predictive biomarkers for low-dose IL-2 therapy efficacy in systemic lupus erythematosus: a clinical analysis","volume":"26","author":"Feng","year":"2024","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cell.2025.11.035_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114938","article-title":"An IL-2 mutein increases regulatory T cell suppression of dendritic cells via IL-10 and CTLA-4 to promote T cell anergy","volume":"43","author":"Jamison","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2025.11.035_bib93","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/ard-2022-222501","article-title":"Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial","volume":"81","author":"Humrich","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cell.2025.11.035_bib94","article-title":"A Comprehensive Review of Low-Dose Interleukin-2 (IL-2) Therapy for Systemic Lupus Erythematosus: Mechanisms, Efficacy, and Clinical Applications","volume":"16","author":"Farooq","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.cell.2025.11.035_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002139","article-title":"Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial","volume":"13","author":"Todd","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.cell.2025.11.035_bib96","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00125-020-05200-w","article-title":"Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I\/II randomised, double-blind, placebo-controlled, dose-finding study","volume":"63","author":"Rosenzwajg","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.cell.2025.11.035_bib97","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.cell.2020.09.054","article-title":"HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis","volume":"183","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2025.11.035_bib98","article-title":"Tregs with an MHC class II peptide-specific chimeric antigen receptor prevent autoimmune diabetes in mice","volume":"133","author":"Spanier","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cell.2025.11.035_bib99","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159925","article-title":"Immune tolerance against infused FVIII in hemophilia A is mediated by PD-L1+ Tregs","volume":"132","author":"Becker-Gotot","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cell.2025.11.035_bib100","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400249","article-title":"Clinical Safety and Preliminary Efficacy of Regulatory T Cells for ALS","volume":"4","author":"Shneider","year":"2025","journal-title":"NEJM Evid."},{"key":"10.1016\/j.cell.2025.11.035_bib101","doi-asserted-by":"crossref","first-page":"7668","DOI":"10.7150\/thno.75965","article-title":"Adoptive therapy with amyloid-beta specific regulatory T cells alleviates Alzheimer's disease","volume":"12","author":"Yang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.cell.2025.11.035_bib102","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood-2006-05-025072","article-title":"Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning","volume":"109","author":"Rao","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cell.2025.11.035_bib103","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2025.11.035_bib104","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41573-020-00092-2","article-title":"B cell depletion therapies in autoimmune disease: advances and mechanistic insights","volume":"20","author":"Lee","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cell.2025.11.035_bib105","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2025.11.035_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.893576","article-title":"A Novel GMP Protocol to Produce High-Quality Treg Cells From the Pediatric Thymic Tissue to Be Employed as Cellular Therapy","volume":"13","author":"Bernaldo-de-Quir\u00f3s","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib107","doi-asserted-by":"crossref","first-page":"E3246","DOI":"10.1073\/pnas.1421463112","article-title":"Inflammation negatively regulates FOXP3 and regulatory T-cell function via DBC1","volume":"112","author":"Gao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2025.11.035_bib108","doi-asserted-by":"crossref","first-page":"E3432","DOI":"10.1073\/pnas.1408780111","article-title":"Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions","volume":"111","author":"Lu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2025.11.035_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00038","article-title":"Automated Clinical Grade Expansion of Regulatory T Cells in a Fully Closed System","volume":"10","author":"Mar\u00edn Morales","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib110","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adr6049","article-title":"Generating functionally stable and antigen-specific Treg cells from effector T cells for cell therapy of inflammatory diseases","volume":"17","author":"Mikami","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2025.11.035_bib111","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg6986","article-title":"A human orthogonal IL-2 and IL-2Rbeta system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia","volume":"13","author":"Zhang","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2025.11.035_bib112","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2012.05.027","article-title":"STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease","volume":"37","author":"Laurence","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2025.11.035_bib113","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/bloodadvances.2019000965","article-title":"Coexpression of FOXP3 and a Helios isoform enhances the effectiveness of human engineered regulatory T cells","volume":"4","author":"Seng","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.cell.2025.11.035_bib114","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.immuni.2015.07.017","article-title":"Hydrogen Sulfide Promotes Tet1- and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis","volume":"43","author":"Yang","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2025.11.035_bib115","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1053\/j.gastro.2011.09.015","article-title":"Gut-tropic T cells that express integrin \u03b14\u03b27 and CCR9 are required for induction of oral immune tolerance in mice","volume":"141","author":"Cassani","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cell.2025.11.035_bib116","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/ajt.17063","article-title":"Anti-HLA-A2-CAR Tregs prolong vascularized mouse heterotopic heart allograft survival","volume":"22","author":"Wagner","year":"2022","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.cell.2025.11.035_bib117","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav1648","article-title":"Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus","volume":"11","author":"Kansal","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2025.11.035_bib118","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-60082-z","article-title":"Expression of an interleukin-2 partial agonist enhances regulatory T cell persistence and efficacy in mouse autoimmune models","volume":"16","author":"Robert","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2025.11.035_bib119","article-title":"Metabolic reprogramming of naive regulatory T cells by IL-7 and IL-15 promotes their persistence and performance upon adoptive transfer","volume":"8","author":"Filoni","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.cell.2025.11.035_bib120","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1073\/pnas.1620835114","article-title":"IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors","volume":"114","author":"Whitehouse","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2025.11.035_bib121","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/bloodadvances.2023011625","article-title":"Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD","volume":"8","author":"Bader","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.cell.2025.11.035_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00472","article-title":"Glucocorticoid Receptor-Deficient Foxp3+ Regulatory T Cells Fail to Control Experimental Inflammatory Bowel Disease","volume":"10","author":"Rocamora-Reverte","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib123","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.it.2023.04.005","article-title":"Engineered Treg cells as putative therapeutics against inflammatory diseases and beyond","volume":"44","author":"Bittner","year":"2023","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cell.2025.11.035_bib124","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2011-02-337360","article-title":"A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells","volume":"118","author":"Wang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cell.2025.11.035_bib125","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci. Transl. Med."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867425013704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867425013704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:18:43Z","timestamp":1791375523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867425013704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0092867425013704"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2025.11.035","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next steps in regulatory T cells: Biology and clinical application","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2025.11.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}